OBJECTIVE: To estimate prevalence and progression to dementia of cognitive impairment, no dementia (CIND), mild cognitive impairment (MCI), and relative subtypes, evaluating the relationships with daily functioning, cardiovascular diseases and vascular risk factors. METHODS: We evaluated CIND and MCI in the Italian Longitudinal Study on Aging. The neuropsychological battery assessed global cognitive function, memory and attention. Two thousand eight hundred thirty participants were examined at baseline and after a mean follow-up of 3.9 +/- 0.7 years. RESULTS: The prevalence was 9.5% for CIND and 16.1% for MCI. Prevalence rates for CIND subtypes were 1.8% for amnestic, 2.3% for single nonmemory, 1.5% for multidomain, and 3.9% for CIND defined only on global cognitive function. The prevalence was 7.0% for amnestic, 7.8% for single nonmemory, and 1.3% for multidomain MCI. Incidence of dementia (per 1,000 person-years) was 7.63 in the total sample, 21.37 in CIND, and 13.59 in MCI. In MCI, rates ranged from 8.74 in amnestic to 40.60 in multidomain subtype. The highest incidence of 56.02 per 1,000 person-years was found in multidomain CIND. Both CIND and MCI increased by almost three times the risk of dementia at follow-up. Among baseline variables, only previous stroke and impairment in instrumental activities of daily living significantly increased the risk of dementia at follow-up. CONCLUSIONS: Both cognitive impairment, no dementia and mild cognitive impairment are frequent in the Italian elderly (2,955,000 prevalent cases expected) and significantly predict progression to dementia. Individuation of subgroups with different risk factors and transition rates to dementia is required to plan early and cost-effective interventions.
OBJECTIVE: To estimate prevalence and progression to dementia of cognitive impairment, no dementia (CIND), mild cognitive impairment (MCI), and relative subtypes, evaluating the relationships with daily functioning, cardiovascular diseases and vascular risk factors. METHODS: We evaluated CIND and MCI in the Italian Longitudinal Study on Aging. The neuropsychological battery assessed global cognitive function, memory and attention. Two thousand eight hundred thirty participants were examined at baseline and after a mean follow-up of 3.9 +/- 0.7 years. RESULTS: The prevalence was 9.5% for CIND and 16.1% for MCI. Prevalence rates for CIND subtypes were 1.8% for amnestic, 2.3% for single nonmemory, 1.5% for multidomain, and 3.9% for CIND defined only on global cognitive function. The prevalence was 7.0% for amnestic, 7.8% for single nonmemory, and 1.3% for multidomain MCI. Incidence of dementia (per 1,000 person-years) was 7.63 in the total sample, 21.37 in CIND, and 13.59 in MCI. In MCI, rates ranged from 8.74 in amnestic to 40.60 in multidomain subtype. The highest incidence of 56.02 per 1,000 person-years was found in multidomain CIND. Both CIND and MCI increased by almost three times the risk of dementia at follow-up. Among baseline variables, only previous stroke and impairment in instrumental activities of daily living significantly increased the risk of dementia at follow-up. CONCLUSIONS: Both cognitive impairment, no dementia and mild cognitive impairment are frequent in the Italian elderly (2,955,000 prevalent cases expected) and significantly predict progression to dementia. Individuation of subgroups with different risk factors and transition rates to dementia is required to plan early and cost-effective interventions.
Authors: John J Hanfelt; Joanne Wuu; Ann B Sollinger; Melanie C Greenaway; James J Lah; Allan I Levey; Felicia C Goldstein Journal: Am J Geriatr Psychiatry Date: 2011-11 Impact factor: 4.105
Authors: Amy J Jak; Katherine J Bangen; Christina E Wierenga; Lisa Delano-Wood; Jody Corey-Bloom; Mark W Bondi Journal: Int Rev Neurobiol Date: 2009 Impact factor: 3.230
Authors: David J Libon; Mark W Bondi; Catherine C Price; Melissa Lamar; Joel Eppig; Denene M Wambach; Christine Nieves; Lisa Delano-Wood; Tania Giovannetti; Carol Lippa; Anahid Kabasakalian; Stephanie Cosentino; Rod Swenson; Dana L Penney Journal: J Int Neuropsychol Soc Date: 2011-09 Impact factor: 2.892
Authors: Emilie T Reas; Gail A Laughlin; Jaclyn Bergstrom; Donna Kritz-Silverstein; Elizabeth Barrett-Connor; Linda K McEvoy Journal: Am J Geriatr Psychiatry Date: 2017-03-16 Impact factor: 4.105
Authors: Ronald C Petersen; Rosebud O Roberts; David S Knopman; Bradley F Boeve; Yonas E Geda; Robert J Ivnik; Glenn E Smith; Clifford R Jack Journal: Arch Neurol Date: 2009-12
Authors: K Narasimhalu; S Ang; D A De Silva; M-C Wong; H-M Chang; K-S Chia; A P Auchus; C Chen Journal: Neurology Date: 2009-12-01 Impact factor: 9.910